Article Information
History
- March 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Maria S. Lightowlera,*,
- Portia Manangazirab,
- Fabienne Nackersa,
- Michel Van Herp,
- Isaac Phirib,
- Kuziwa Kuwenyic,
- Isabella Panunzic,
- Daniela Garonec,
- Farayi Marumec,
- Andrew Tarupiwad,
- Eva Ferrerasa,
- Clemence Durie and
- Francisco J. Luqueroa
- aEpicentre, 34 Avenue Jean Jaurès, 70519 Paris, France
- bMinistry of Health and Child Welfare, Epidemiology and Disease Control Directorate, Harare, Zimbabwe
- cMédecins Sans Frontières, 46, Rue de l’Arbre Bénit, 1050 Brussels, Belgium
- dNational Microbiology Reference laboratory, Harare, Zimbabwe
- eHarare City Department of Health, Harare, Zimbabwe
- ↵*Corresponding author E-mail address: maria.lightowler{at}brussels.msf.org
Posted March 31, 2022.
Effectiveness of Typhoid Conjugate Vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study
